Proparacaine Hydrochloride PROPARACAINE HYDROCHLORIDE NUCARE PHARMACEUTICALS,INC. FDA Approved Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula: Established name: Proparacaine Hydrochloride Chemical name: Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester, monohydrochloride Molecular weight: 330.85 Each mL contains: Active : proparacaine hydrochloride 5 mg (0.5%). Inactives : glycerin and purified water. The pH may be adjusted with hydrochloric acid and/or sodium hydroxide. Preservative: b enzalkonium chloride (0.01%). Proparacaine Hydrochloride (structural formula)
FunFoxMeds bottle
Route
OPHTHALMIC
Applications
ANDA040074
Package NDC

Drug Facts

Composition & Profile

Strengths
0.5 % 15 ml
Quantities
5 bottles 15 ml
Treats Conditions
Indications And Usage Proparacaine Hydrochloride Ophthalmic Solution Is Indicated For Procedures In Which A Topical Ophthalmic Anesthetic Is Indicated Corneal Anesthesia Of Short Duration E G Tonometry Gonioscopy Removal Of Corneal Foreign Bodies And For Short Corneal And Conjunctival Procedures

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UPC
0368071436853
UNII
U96OL57GOY
Packaging

HOW SUPPLIED Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% is supplied in a plastic bottle with a controlled drop tip and a white polypropylene cap in the following size: NDC 68071-4368-5 bottles of 15mL; PRINCIPAL DISPLAY PANEL pdp

Package Descriptions
  • HOW SUPPLIED Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% is supplied in a plastic bottle with a controlled drop tip and a white polypropylene cap in the following size: NDC 68071-4368-5 bottles of 15mL
  • PRINCIPAL DISPLAY PANEL pdp

Overview

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula: Established name: Proparacaine Hydrochloride Chemical name: Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester, monohydrochloride Molecular weight: 330.85 Each mL contains: Active : proparacaine hydrochloride 5 mg (0.5%). Inactives : glycerin and purified water. The pH may be adjusted with hydrochloric acid and/or sodium hydroxide. Preservative: b enzalkonium chloride (0.01%). Proparacaine Hydrochloride (structural formula)

Indications & Usage

Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated; corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies and for short corneal and conjunctival procedures.

Dosage & Administration

Usual dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% should be clear, colorless to faint yellow color. If the solution becomes darker, discard the solution. FOR TOPICAL OPHTHALMIC USE ONLY

Warnings & Precautions
WARNINGS NOT FOR INJECTION INTO THE EYE - FOR TOPICAL OPHTHALMIC USE ONLY Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.
Contraindications

Proparacaine hydrochloride ophthalmic solution is contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.

Adverse Reactions

Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and sometimes iritis with descemetitis has been reported. Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has been reported. To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Storage & Handling

Storage Refrigerate at 2°-8°C (36°- 46°F). Protect from light. Keep tightly closed. DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT. KEEP OUT OF REACH OF CHILDREN. Revised: July 2016 Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA ©Bausch & Lomb Incorporated 9114403 (Folded) 9114503 (Flat)


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →